Novozymes A/S Company Profile (OTCMKTS:NVZMY)

About Novozymes A/S

Novozymes A/S logoNovozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions. The Food & Beverages (old Food & Beverages Enzymes) manufactures enzymes for the food industry. The Bioenergy (old Bioenergy Enzymes) provides enzymes to the energy industry. The Agriculture & Feed area combines old Feed & Other Technical Enzymes area (enzymes sales to the feed industry) and microorganism sales for aquaculture and agriculture. The Technical & Pharma area combines old Feed & Other Technical Enzymes area (enzymes to other technical industries), microorganism sales for wastewater treatment, and Biopharma (recombinant ingredients and technologies).

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: NVZMY
  • CUSIP:
Key Metrics:
  • Previous Close: $43.17
  • 50 Day Moving Average: $46.60
  • 200 Day Moving Average: $46.04
  • 52-Week Range: $37.98 - $49.55
  • Trailing P/E Ratio: 29.65
  • Foreward P/E Ratio: 25.70
  • P/E Growth: 3.65
  • Market Cap: $12.97B
  • Outstanding Shares: 300,399,000
  • Beta: 0.75
Additional Links:
Companies Related to Novozymes A/S:

Analyst Ratings

Consensus Ratings for Novozymes A/S (OTCMKTS:NVZMY) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Novozymes A/S (OTCMKTS:NVZMY)
Show:
DateFirmActionRatingPrice TargetDetails
1/20/2016Goldman Sachs Group Inc.UpgradeSell -> NeutralView Rating Details
8/7/2015Nordea Equity ResearchDowngradeBuy -> HoldView Rating Details
4/16/2015DanskeDowngradeBuy -> HoldView Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Novozymes A/S (OTCMKTS:NVZMY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/22/2015$0.36$0.36ViewN/AView Earnings Details
8/6/2015$0.35$0.33ViewN/AView Earnings Details
4/24/2015$0.33$0.33ViewN/AView Earnings Details
1/20/2015$0.23$0.30ViewN/AView Earnings Details
10/27/2014$0.35$0.34ViewN/AView Earnings Details
8/15/2014$0.38$0.34ViewN/AView Earnings Details
5/20/2014$0.33$0.40ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Novozymes A/S (OTCMKTS:NVZMY)
Current Year EPS Consensus Estimate: $1.53 EPS
Next Year EPS Consensus Estimate: $1.68 EPS

Dividends

Dividend History for Novozymes A/S (OTCMKTS:NVZMY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Novozymes A/S (OTCMKTS:NVZMY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Novozymes A/S (OTCMKTS:NVZMY)
DateHeadline
capitalcube.com logoETF’s with exposure to Novozymes A/S : August 29, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - August 29 at 6:20 PM
capitalcube.com logoNovozymes A/S :NVZMY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - August 12 at 6:41 PM
marketrealist.com logoHow Portfolio Shifts Are Affecting Fidelity’s Europe Fund (OTCMKTS:NVZMY)
marketrealist.com - August 5 at 9:40 AM
capitalcube.com logoETF’s with exposure to Novozymes A/S : June 30, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - June 30 at 12:25 PM
capitalcube.com logoNovozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - June 3 at 11:29 AM
News IconLatest Analyst Ratings For Novozymes A/S - (NVZMY) - Share Trading News (OTCMKTS:NVZMY)
www.sharetrading.news - May 26 at 12:44 PM
finance.yahoo.com logoConsumer Staples Delivered Top-Notch Performance for VGEAX (OTCMKTS:NVZMY)
finance.yahoo.com - April 29 at 9:08 AM
capitalcube.com logoETF’s with exposure to Novozymes A/S : March 29, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - March 29 at 11:03 AM
capitalcube.com logoNovozymes A/S :NVZMY-US: Earnings Analysis: Q4, 2015 By the Numbers (OTCMKTS:NVZMY)
www.capitalcube.com - March 28 at 11:46 AM
finance.yahoo.com logoAn Above-Average Year for FHJUX (OTCMKTS:NVZMY)
finance.yahoo.com - March 21 at 12:29 PM
finance.yahoo.com logoThe Fidelity Advisor Europe Fund: An Above-Average Year (OTCMKTS:NVZMY)
finance.yahoo.com - February 22 at 7:03 PM
News IconLatest Analysts Reports On Novozymes A/S - (NVZMY) - Risers & Fallers (OTCMKTS:NVZMY)
www.risersandfallers.com - February 5 at 2:43 PM
seekingalpha.com logoKerry Group Plc - The Biggest Fish In The Highly Fragmented Ingredient Market - Seeking Alpha (OTCMKTS:NVZMY)
seekingalpha.com - January 30 at 1:44 PM
News IconRecent Broker Updates On Novozymes A/S - (NVZMY) - Risers & Fallers (OTCMKTS:NVZMY)
www.risersandfallers.com - January 28 at 1:57 PM
finance.yahoo.com logoHow the Fidelity Advisor Europe Fund Allocated Its Portfolio in 2015 (OTCMKTS:NVZMY)
finance.yahoo.com - January 25 at 4:11 PM
capitalcube.com logoNovozymes A/S Earnings Analysis: Q4, 2015 By the Numbers (OTCMKTS:NVZMY)
www.capitalcube.com - January 21 at 12:22 PM
finance.yahoo.com logoNovozymes upgraded by Goldman (OTCMKTS:NVZMY)
finance.yahoo.com - January 20 at 8:22 AM
marketwatch.com logoNovozymes profit up; sees moderate growth in 2016 - MarketWatch (OTCMKTS:NVZMY)
www.marketwatch.com - January 19 at 12:34 PM
marketwatch.com logoNovozymes profit up; sees moderate growth in 2016 (OTCMKTS:NVZMY)
www.marketwatch.com - January 19 at 12:34 PM
News IconAnalysts Bullish on Novozymes A S - ADR (NVZMY) EPS - OctaFinance.com (OTCMKTS:NVZMY)
www.octafinance.com - January 18 at 7:43 PM
finance.yahoo.com logoA Look at FHJUX’s Portfolio through November 2015 (OTCMKTS:NVZMY)
finance.yahoo.com - December 23 at 5:00 PM
finance.yahoo.com logoThe Fidelity Advisor Europe Fund Class A (FHJUX): Historical Overview (OTCMKTS:NVZMY)
finance.yahoo.com - October 28 at 2:02 PM
capitalcube.com logoNovozymes A/S Earnings Q3, 2015 (OTCMKTS:NVZMY)
www.capitalcube.com - October 27 at 11:18 AM
capitalcube.com logoNovozymes A/S – Value Analysis (US OTC:NVZMY) : October 23, 2015 (OTCMKTS:NVZMY)
www.capitalcube.com - October 23 at 2:02 PM
finance.yahoo.com logoThere is uncertainty around biofuels: Novzymes CEO (OTCMKTS:NVZMY)
finance.yahoo.com - October 22 at 2:15 AM
capitalcube.com logoNovozymes A/S Q2 Earnings Analysis: By the Numbers, 2015 (OTCMKTS:NVZMY)
www.capitalcube.com - August 24 at 1:40 PM
finance.yahoo.com logoNovozyme earnings weaker than expected (OTCMKTS:NVZMY)
finance.yahoo.com - August 6 at 2:15 AM
thestreet.com logoEuropean Stocks Rise on Climb in German Investor Confidence (OTCMKTS:NVZMY)
www.thestreet.com - January 20 at 6:24 AM
sg.finance.yahoo.com logoScience on the job: Teachers learn from tech firms (OTCMKTS:NVZMY)
sg.finance.yahoo.com - July 26 at 10:36 AM

Social

Novozymes A/S (OTCMKTS:NVZMY) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff